4.7 Article

Mitochondria-targeted ROS- and GSH-responsive diselenide-crosslinked polymer dots for programmable paclitaxel release

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jiec.2021.04.016

关键词

Polymer dot; GSH-responsive delivery; Cancer therapy; Mitochondria targeting; ROS sensitive

资金

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) [2020R1A2B5B02001500, 2018R1A6A1A03023788, 2019R1A2C1009356]
  2. Korea Institute for Advancement of Technology (KIAT) - Korea Government (MOTIE) [P00008500]
  3. National Research Foundation of Korea [2020R1A2B5B02001500, 2019R1A2C1009356] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The design of ROS- and GSH-responsive PTX-loaded polymer dot with mitochondria-targeting capability allows for selective release of PTX in cancer cells, leading to enhanced apoptosis and reduced effects on normal cells.
Enhancing therapeutic efficacy of drugs from reactive oxygen species (ROS) and glutathione (GSH)responsive matrix and minimizing toxic effects on normal cells remains a challenge in programmable anticancer drug delivery. Herein, ROS- and GSH-responsive paclitaxel (PTX)-loaded polymer dot (PD) with mitochondria-targeting capability was designed by constructing diselenide linkage and triphenylphosphonium (TPP) for tunable PTX release and fluorescence for cancer theranostics. PD-TPP nanocarrier could improve the PTX stability after loading (PD-TPP(PTX)), and the cleavage of diselenide bond in the presence of H2O2 and GSH triggered the controllable PTX release, providing higher fluorescence intensity. As the levels of H2O2 and GSH are higher in cancer cells compared to normal cells, PTX was selectively released from PD-TPP in cancer cells, reducing cell viability (similar to 25%) and causing enhanced apoptosis of cancer cells compared to normal cells. The PD-TPP(PTX) selectivity was also reflected by distinct fluorescence intensity in HeLa and PC-3 cells (cancer) compared to CHO-K1 cells (normal). Furthermore, conjugated TPP promoted the PD-TPP(PTX) accumulation in mitochondria due to specific targeting of TPP towards mitochondria, allowing PTX release in mitochondria of cancer cells. Hence, this approach could be a potential strategy to enhance therapeutic efficacy of cancer drugs and minimize the side effects on normal cells. (C) 2021 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据